Willis Towers Watson

WTW Financials Market cap $29.8B as of Oct 29, 2026 16:00 ET S&P 500

Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 29, 2026

Revenue$2.46B +8% year over year

Operating profit$0.40B 16% margin

Net profit$0.30B 12% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.46	100%	+8%
Health wealth & career	1.37	56%	+7%
Risk & broking	1.09	44%	+8%
Operating expenses	−2.06	84%
Compensation	−1.51	61%	+0pp
Interest	−0.08	3%	+0pp
Underwriting	−0.35	15%	−1pp
Other	−0.12	5%
Operating profit	0.40	16% margin	−1pp
Interest & other costs	−0.02
Tax	−0.08
Net profit	0.30	12% margin	−1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.47	100%	+9%
Health wealth & career	1.29	53%	+8%
Risk & broking	1.17	47%	+11%
Corporate	0.01	0%	−54%
Operating expenses	−2.17	88%
Compensation	−1.55	63%	−1pp
Interest	−0.08	3%	+0pp
Underwriting	−0.38	15%	+1pp
Other	−0.17	7%
Operating profit	0.29	12% margin	−2pp
Tax	−0.06
Net profit	0.23	9% margin	−5pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	2.41	100%	+9%
Health wealth & career	1.28	53%	+9%
Risk & broking	1.12	47%	+9%
Corporate	0.01	0%	−18%
Operating expenses	−2.04	84%
Compensation	−1.43	59%	+0pp
D&A	−0.06	2%	+0pp
Interest	−0.08	3%	+0pp
Underwriting	−0.39	16%	+0pp
Other	−0.08	4%	+0pp
Operating profit	0.38	16% margin	+2pp
Tax	−0.08
Net profit	0.30	12% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.94	100%	−3%
Health wealth & career	1.67	57%	−11%
Risk & broking	1.26	43%	+10%
Corporate	0.01	0%	−47%
Operating expenses	−1.99	68%
Compensation	−1.44	49%	+4pp
Interest	−0.07	2%	+0pp
Underwriting	−0.36	12%	−5pp
Other	−0.13	5%	+0pp
Operating profit	0.95	32% margin	−23pp
Interest & other costs	−0.02
Tax	−0.20
Net profit	0.74	25% margin	−16pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.29	100%	+0%
Health wealth & career	1.28	56%	−5%
Risk & broking	1.01	44%	+7%
Operating expenses	−1.90	83%
Compensation	−1.41	62%	+1pp
Interest	−0.07	3%	+0pp
Underwriting	−0.35	15%	−3pp
Other	−0.07	3%	+0pp
Operating profit	0.39	17% margin	+104pp
Tax	−0.09
Net profit	0.30	13% margin	+86pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.26	100%	+0%
Health wealth & career	1.20	53%	−6%
Risk & broking	1.05	46%	+7%
Corporate	0.01	1%	+63%
Operating expenses	−1.95	86%
Compensation	−1.45	64%	+2pp
Interest	−0.06	3%	+0pp
Underwriting	−0.34	15%	−5pp
Other	−0.10	4%	+0pp
Operating profit	0.31	14% margin	+6pp
Tax benefit	0.02
Net profit	0.33	15% margin	+8pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	2.22	100%	−5%
Health wealth & career	1.18	53%	−13%
Risk & broking	1.03	46%	+5%
Corporate	0.01	1%	+57%
Operating expenses	−1.92	86%
Compensation	−1.32	60%	+2pp
D&A	−0.05	2%	+0pp
Interest	−0.07	3%	+0pp
Underwriting	−0.37	16%	−3pp
Other	−0.11	5%	+0pp
Operating profit	0.30	14% margin	+3pp
Tax	−0.07
Net profit	0.24	11% margin	+2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 29, 2026 Operating margin 16% Net profit $0.30B	Jul 1 – Sep 30, 2026	Oct 29, 2026	$2.46B	+8%	16%	$0.30B	12%
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 30, 2026 Operating margin 12% Net profit $0.23B	Apr 1 – Jun 30, 2026	Jul 30, 2026	$2.47B	+9%	12%	$0.23B	9%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 30, 2026 Operating margin 16% Net profit $0.30B	Jan 1 – Mar 31, 2026	Apr 30, 2026	$2.41B	+9%	16%	$0.30B	12%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 25, 2026 Operating margin 32% Net profit $0.74B	Oct 1 – Dec 31, 2025	Feb 25, 2026	$2.94B	−3%	32%	$0.74B	25%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 30, 2025 Operating margin 17% Net profit $0.30B	Jul 1 – Sep 30, 2025	Oct 30, 2025	$2.29B	+0%	17%	$0.30B	13%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Aug 1, 2025 Operating margin 14% Net profit $0.33B	Apr 1 – Jun 30, 2025	Aug 1, 2025	$2.26B	+0%	14%	$0.33B	15%
Q1 FY25 Jan 1 – Mar 31, 2025 reported Apr 24, 2025 Operating margin 14% Net profit $0.24B	Jan 1 – Mar 31, 2025	Apr 24, 2025	$2.22B	−5%	14%	$0.24B	11%